Monday, April 20, 2026 | 07:19 PM ISTहिंदी में पढें
Astrazeneca Pharma India Ltd
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel
02:53 PM, 1st Dec 2023
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform you that based on the recommendation of Nomination and Remuneration Committee the Board of Directors of the Company has approved the appointment of Mr. Venkat Natarajan as Lead - Market Access with effect from January 2 2024.